References
- Braga-Mele R, Chang DF, Henderson BA, et al. (2014). Intracameral antibiotics: safety, efficacy, and preparation. J Cataract Refract Surg 40:2134–42.
- Daien V, Papinaud L, Gillies MC, et al. (2016). Effectiveness and safety of an intracameral injection of cefuroxime for the prevention of endophthalmitis after cataract surgery with or without perioperative capsular rupture. JAMA Ophthalmol 134:810–6.
- Damico FM, Gasparin F, Ioshimoto GL, et al. (2017). Intravitreal injection of polysorbate 80: a functional and morphological study. Rev Col Bras Cir 44:603–11.
- Davies B, Morris T. (1993). Physiological parameters in laboratory animals and humans. Pharm Res 10:1093–5.
- De Majumdar S, Subinya M, Korward J, et al. (2017). A low concentration of tacrolimus/semifluorinated alkane (SFA) eyedrop suppresses intraocular inflammation in experimental models of uveitis. Curr Mol Med 17:211–20.
- Del Amo EM, Urtti A. (2015). Rabbit as an animal model for intravitreal pharmacokinetics: clinical predictability and quality of the published data. Exp Eye Res 137:111–24.
- Del Amo EM, Rimpelä AK, Heikkinen E, et al. (2017). Pharmacokinetic aspects of retinal drug delivery. Prog Retin Eye Res 57:134–85.
- Delyfer MN, Rougier MB, Leoni S, et al. (2011). Ocular toxicity after intracameral injection of very high doses of cefuroxime during cataract surgery. J Cataract Refract Surg 37:271–8.
- Dumouchel JL, Chemuturi N, Milton MN, et al. (2018). Models and approaches describing the metabolism, transport, and toxicity of drugs administered by the ocular route. Drug Metab Dispos 46:1670–83.
- Estlack Z, Bennet D, Reid T, Kim J. (2017). Microengineered biomimetic ocular models for ophthalmological drug development. Lab Chip 17:1539–51.
- Kamal-Salah R, Osoba O, Doyle E. (2017). Ocular toxicity after inadvertent intracameral injection of high dose of cefuroxime during cataract surgery: a case series. Retin Cases Brief Rep 13:269–72..
- Koul S, Philipson A, Philipson BT, Arvidson S. (1993). Intraocular levels of cefuroxime in inflamed rabbit eyes. Eur J Ophthalmol 3:61–5.
- Koul S, Philipson A, Philipson BT, et al. (1990). Intraocular levels of cefuroxime in uninflamed rabbit eyes. Acta Ophthalmol (Copenh) 68:455–65.
- Partani P, Gurule S, Khuroo A, et al. (2010). Liquid chromatography/electrospray tandem mass spectrometry method for the determination of cefuroxime in human plasma: application to a pharmacokinetic study. J Chromatogr B 878:428–34.
- Pelletier AL, Rojas-Roldan L, Coffin J. (2016). Vision loss in older adults. Am Fam Physician 94:219–26.
- Razeghinejad MR, Pro MJ, Katz LJ. (2011). Non-steroidal drug-induced glaucoma. Eye (Lond) 25:971–80.
- Richards AB, Bron AJ, Mc Lendon B, et al. (1979). The intraocular penetration of cefuroxime after parenteral administration. Br J Ophthalmol 63:687–9.
- Safneck JR. (2012). Endophthalmitis: a review of recent trends. Saudi J Ophthalmol 26:181–9.
- Ta CN, Chang RT, Singh K, et al. (2003). Antibiotic resistance patterns of ocular bacterial flora: a prospective study of patients undergoing anterior segment surgery. Ophthalmology 110:1946–51.
- Wong DC, Waxman MD, Herrinton LJ, Shorstein NH. (2015). Transient macular edema after intracameral injection of a moderately elevated dose of cefuroxime during phacoemulsification surgery. JAMA Ophthalmol 133:1194–7.
- Yin VT, Weisbrod DJ, Eng KT, et al. (2013). Antibiotic resistance of ocular surface flora with repeated use of a topical antibiotic after intravitreal injection. JAMA Ophthalmol 131:456–61.
- Yoeruek E, Spitzer MS, Saygili O, et al. (2008). Comparison of in vitro safety profiles of vancomycin and cefuroxime on human corneal endothelial cells for intracameral use. J Cataract Refract Surg 34:2139–45.
- Yoshizumi MO, Niizawa JM, Meyers-Elliott R. (1986). Ocular toxicity of intravitreal vidarabine solubilized in dimethyl sulfoxide. Arch Ophthalmol 104:426–30.